Status:
COMPLETED
Acupressure for Post-Treatment Cancer Fatigue
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
University of Michigan Rogel Cancer Center
Conditions:
Fatigue
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Persistent cancer related fatigue (PCRF) is a common symptom experienced by many cancer survivors, which may last for as long as 10 years following treatment. PCRF is currently under diagnosed, with b...
Eligibility Criteria
Inclusion
- People aged 18 years of age and older
- A diagnosis of cancer, except for squamous and basal cell carcinomas, who had completed their cancer-related treatments at least 12 weeks prior (except for on-going hormone therapy, which must have been initiated at least three weeks prior to enrollment
- To have a complaint of persistent, moderate to severe fatigue despite standard treatment \[defined as \> 4 on the Brief Fatigue Inventory (BFI)\]
- To maintain their typical dietary patterns, especially the use of caffeinated beverages throughout the study,
- To be disease free and be acupuncture and acupressure naïve
Exclusion
- Diagnosed with anemia \[defined as hemoglobin levels \< 12 gm/dl\] or receiving treatment for anemia
- Have any comorbidities likely to cause significant fatigue (i.e., moderate to severe heart failure, hypothyroidism) either currently or before cancer diagnosis
- Have problems with easy or spontaneous bruising from any cause, e.g. bleeding disorders
- Have nutritional deficiencies \[defined by albumin levels \< 35 g/liter\]
- Have a diagnosis of depression and are not receiving active successful treatment for depression or have a HADS depression score of ≥ 11had a diagnosis of depression and are not receiving active successful treatment for depression or have a HADS depression score of ≥ 11
- Have a thyroid disorder, defined as either thyroid stimulating hormone or free T4 lower than the normal range or greater than 2xs the upper range
- Have an anticipated survival rate of less than 6 months
- Have an initiation, a cessation or change of dose (up to three weeks prior to the study's start) of any chronic medications or dietary supplements or any planned change of chronic medications or dietary supplements during the study
- and are pregnant or lactating
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00959998
Start Date
September 1 2007
End Date
July 1 2009
Last Update
June 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Health System
Ann Arbor, Michigan, United States, 48104